clinicaltrialsarena17h
First blood-stage malaria vaccine ‘a much-needed addition’ – analyst
Following positive Phase IIb trial results, RH5.1/Matrix-M has the potential to be the first blood-stage malaria vaccine brought to market.
clinicaltrialsarena19h
Alumis reports positive outcomes from Phase I trial of TYK2 inhibitor
Alumis has revealed encouraging results from a Phase I clinical trial of tyrosine kinase 2 (TYK2), A-005, in healthy subjects.
clinicaltrialsarena20h
Novo Nordisk takes a hit as CagriSema underperforms in weight loss
Novo Nordisk has announced positive results from its Phase III trial of CagriSema but fell short of a previously promised 25% weight loss.
clinicaltrialsarena22h
Adicet Bio doses first subject in Phase I trial of renal cell carcinoma therapy
Adicet Bio has dosed the first subject in a multicentre Phase I trial of ADI-270, a gamma delta CAR T-cell therapy for treating ccRCC.
clinicaltrialsarena22h
Sorriso Pharma’s UC treatment hits Phase Ib endpoints
Sorriso Pharmaceuticals announced that it is looking to move to Phase II after its ulcerative colitis treatment saw success over placebo.